Lataa...
Hepatic Arterial Infusion Chemotherapy versus Sorafenib in Patients with Advanced Hepatocellular Carcinoma
BACKGROUND: Prior to the approval of sorafenib, hepatic arterial infusion chemotherapy (HAIC) was offered to patients with advanced hepatocellular carcinoma (HCC) in East Asia, particularly Japan. According to the Japanese guidelines, HAIC is recommended as one of the treatment options in patients w...
Tallennettuna:
| Julkaisussa: | Liver Cancer |
|---|---|
| Päätekijät: | , , , , , , , , , , , , , , , , , , , , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
S. Karger AG
2020
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7548914/ https://ncbi.nlm.nih.gov/pubmed/33083282 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1159/000508724 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|